- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 11/02 - Depsipeptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof cyclic, e.g. valinomycins
Patent holdings for IPC class C07K 11/02
Total number of patents in this class: 243
10-year publication summary
|
22
|
23
|
28
|
20
|
14
|
20
|
12
|
15
|
14
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10309 |
14 |
| NovoBiotic Pharmaceuticals, LLC | 23 |
13 |
| Onkure, Inc. | 30 |
11 |
| Chugai Seiyaku Kabushiki Kaisha | 1413 |
10 |
| St. Jude Children's Research Hospital | 238 |
8 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
7 |
| Sirenas LLC | 11 |
5 |
| Bicyclerd Limited | 154 |
5 |
| Kaneka Corporation | 4684 |
4 |
| Pharma Mar, S.A. | 212 |
4 |
| The Regents of the University of Colorado, a body corporate | 2790 |
4 |
| Zoetis Services LLC | 1549 |
4 |
| The Regents of the University of California | 20669 |
3 |
| AureoGen Biosciences, Inc. | 3 |
3 |
| Celgene Corporation | 1409 |
3 |
| The Kitasato Institute | 150 |
3 |
| Meiji Seika Pharma Co., Ltd. | 256 |
3 |
| Merial, Inc. | 211 |
3 |
| University of Utah Research Foundation | 1857 |
3 |
| Animol Discovery, Inc. | 18 |
3 |
| Other owners | 130 |